Priya Rastogi was named chief executive officer of the National Surgical Adjuvant Breast and Bowel Project Foundation, effective July 1. In addition to this new role, she will continue serving as medical director of NSABP.
From left to right: Geoffrey Shapiro, Leif Ellisen and Nancy Lin. Sitting below them is Kornelia Polyak.The Dana-Farber/Harvard Cancer Center, a cancer research consortium comprised of five of Boston’s academic medical centers, including Dana-Farber Cancer Institute and Massachusetts General Hospital, has been awarded an NCI grant to continue its Specialized Program of Research Excellence in Breast Cancer.
